Results 211 to 220 of about 67,846 (274)

Trends in hospitalisation, myasthenic crisis and intensive care use in myasthenia gravis: a nationwide population-based study in Spain (2016-2022). [PDF]

Neurol Res Pract
Garrido-Hernández T, Del-Águila-Mejía J, Rodríguez-Camacho M, Martínez-Salmerón MDM, Vélez-Gómez B.   +4 more
europepmc   +1 more source

Differential response to ofatumumab in anti-AChR and anti-MuSK positive myasthenia gravis patients: a single-center retrospective study. [PDF]

Ther Adv Neurol Disord
Zhou Q, Ouyang Y, Jiang F, Zeng Q, He T, Wen Z, Shi G, Dong X, Cai H, Xiang W, Su M, Li K, Yang H.   +12 more
europepmc   +1 more source

Minimal Symptom Expression in Generalized Myasthenia Gravis: A Valuable Patient-Centric Treatment Goal. [PDF]

Eur J Neurol
Meisel A, Uzawa A, Qi CZ, Nowacek D, Guptill J, Howard JF.   +5 more
europepmc   +1 more source

Early versus late add-on therapy in generalized myasthenia gravis: a multicenter real-world cohort study. [PDF]

J Neurol
Oeztuerk M, Huntemann N, Gerischer L, Herdick M, Nelke C, Stascheit F, Hoffmann S, Lehnerer S, Stein M, Schubert C, Schneider-Gold C, Pfeuffer S, Krämer HH, Konen FF, Skripuletz T, Pawlitzki M, Rehmann R, Arat E, Menskes CB, Glaubitz S, Zschüntzsch J, Scherwietes V, Totzeck A, Hagenacker T, Meisel A, Meuth SG, Ruck T.   +26 more
europepmc   +1 more source

Perioperative use of eculizumab in patients with thymoma-associated myasthenia gravis: A preliminary case series of five patients. [PDF]

IBRO Neurosci Rep
Ou Y, Wen Y, Liu Y, Lai M, Wang H, Chen X, Zhang H, Peng Y.   +7 more
europepmc   +1 more source

Disruption of intestinal barrier and immune homeostasis links gut microbiota dysbiosis to aggravated experimental autoimmune myasthenia gravis. [PDF]

Front Cell Infect Microbiol
Tian W, Peng S, Xu F, Kong X, Li Y, Zhang W, Liu Z, Zhang H, Wang J, Wang L.   +9 more
europepmc   +1 more source

Caring beyond the procedure: a qualitative study on thoracic surgery nurses' perspectives on chronic illness experiences of individuals with myasthenia gravis undergoing thymectomy. [PDF]

BMJ Open
Missel M, Donsel PO, Nielsen TF, Secher EL, Medeiros EBZ, Rude K, Højgaard JLS, Viby NE, Birnbaum S, Andersen LK, Petersen RH, Witting N.   +11 more
europepmc   +1 more source

Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis. [PDF]

Clin Cosmet Investig Dermatol
Alzahrani D, Niaz G, Roblah TM, Al-Osaimi AK, Alsulaimani H.   +4 more
europepmc   +1 more source

Risk of New-Onset Myasthenia Gravis Following COVID-19 Infection and Vaccination: A Population-Based Case-Control Study. [PDF]

Eur J Neurol
Kab T, Pardo K, Hellmann MA, Lotan I, Friedman Y, Shochat T, Wilf-Yarkoni A.   +6 more
europepmc   +1 more source

Post Hoc, Sex-Specific Subgroup Analysis of Efgartigimod in Patients With Generalized Myasthenia Gravis From the ADAPT Trial: A Sex and Gender Equity in Research (SAGER) Guidelines Approach. [PDF]

Muscle Nerve
Hoffmann S, Zhao S, Callewaert F, Schoppe S, Rózsa C, Spillane J.   +5 more
europepmc   +1 more source